Enteral Formula Containing Egg Yolk Lecithin Improves Diarrhea

Area of Science:

• Gastroenterology
• Nutritional Science
• Biochemistry

Background:

• Diarrhea is a common complication during enteral nutrition.
• Egg yolk lecithin, an emulsifier, has shown promise in improving diarrhea associated with enteral formulas.

Purpose of the Study:

• To evaluate the efficacy of enteral formula supplemented with egg yolk lecithin in improving diarrhea outcomes.
• To assess the in vitro emulsion stability and in vivo lipid absorption of egg yolk lecithin.

Main Methods:

• Retrospective analysis of patients receiving enteral formula with egg yolk lecithin.
• In vitro assessment of emulsifier stability in artificial gastric juice.
• In vivo studies in bile duct-ligated rats and a rat model of short bowel syndrome using different emulsifiers.

Main Results:

• 13/14 patients experienced improved stool consistency/frequency within 24 hours.
• Egg yolk lecithin maintained emulsion stability in gastric acid, unlike soy or synthetic emulsifiers.
• Enhanced lipid absorption and improved fecal consistency were observed in rat models with egg yolk lecithin.

Conclusions:

• Enteral formula emulsified with egg yolk lecithin promotes lipid absorption by protecting against gastric acid degradation.
• This formulation effectively improves diarrhea, potentially reducing patient and healthcare burdens.